secwatch.observer — SEC 8-K summary
======================================

Issuer:     enGene Therapeutics Inc. (ENGN)
CIK:        0001980845
Form:       8-K
Filed at:   2026-07-17T20:05:21+00:00
Accession:  0001193125-26-307795
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enGene updates corporate presentation; no specific financial or clinical details disclosed
--------------------------------------------------------------------------------

- Filed under Item 7.01; presentation furnished as Exhibit 99.1, not deemed filed.
- Presentation dated July 2026; content not provided in filing excerpt.
- No new material financial, clinical, or operational data available from this filing.
- Tickers: ENGN (common) and ENGNW (warrants) trade on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/0001193125-26-307795-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/engn-20260717.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-307795

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer